Page last updated: 2024-09-03

cp 115953 and ellipticine

cp 115953 has been researched along with ellipticine in 1 studies

Compound Research Comparison

Studies
(cp 115953)
Trials
(cp 115953)
Recent Studies (post-2010)
(cp 115953)
Studies
(ellipticine)
Trials
(ellipticine)
Recent Studies (post-2010) (ellipticine)
20004540178

Protein Interaction Comparison

ProteinTaxonomycp 115953 (IC50)ellipticine (IC50)
Cytochrome P450 1A1Homo sapiens (human)0.0193
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.2
DNA topoisomerase 2-alphaHomo sapiens (human)3.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elsea, SH; Hsiung, Y; Nitiss, JL; Osheroff, N1

Other Studies

1 other study(ies) available for cp 115953 and ellipticine

ArticleYear
A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine.
    The Journal of biological chemistry, 1995, Jan-27, Volume: 270, Issue:4

    Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; DNA Topoisomerases, Type II; Drug Resistance; Ellipticines; Fluoroquinolones; Histidine; Humans; Kinetics; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Quinolones; Recombinant Proteins; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Topoisomerase II Inhibitors; Tyrosine

1995